Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
StemBioSys, Inc. logo — Making Cell Culture Relevant

StemBioSys, Inc.

Making Cell Culture Relevant

Founded 2010 United States San Antonio, United States 11 employees Series B Total: $14.44M Biotechnology, Manufacturing

General Information

Company Name StemBioSys, Inc.
Founded Year 2010
Location United States San Antonio, United States
Founders / Decision Makers
Team member
Employees 11
Industries Biotechnology, Manufacturing
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with StemBioSys, Inc.. To contact StemBioSys, Inc., visit stembiosys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does StemBioSys, Inc. compare?

A PDF of StemBioSys, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting StemBioSys, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About StemBioSys, Inc.

StemBioSys, Inc. is a biotechnology and manufacturing company based in San Antonio, Texas, founded in 2010. The company is in proximity to the University of Texas Health Science Center San Antonio (UTHSC-SA) from which it has licensed proprietary technology for the enhanced isolation, growth, and delivery of stem cells and other challenging-to-culture cells for various applications. The company's core technology, CELLvo™ Matrix, is an advanced 3-dimensional stem cell culture system aimed at replicating the natural environment in which stem cells proliferate. StemBioSys focuses on scale-up activities for its patented core technology with the recent $4.06M Series B investment in May 2018. The company is also strategically positioned to launch its initial product to the stem cell research market. Additionally, StemBioSys has completed the build-out of a cGMP facility in partnership with BioBridge Global, facilitating potential therapeutic applications and business relationships for next-generation product offerings. StemBioSys aims to utilize its disruptive stem cell technology platforms, know-how, and intellectual property to build value for its shareholders. By focusing on the treatment of significant medical disorders, the company aspires to establish the necessary facilities, expertise, discipline, and culture to ensure the highest standards of quality for patients, physicians, researchers, and partners. StemBioSys is poised to play a critical role in the future of stem cell-based medicine.

Business keywords: Stem cell research, Cell culture, Regenerative medicine, Biologic matrices, Biologic product development, Stem cell technology, Biomedical research, Regenerative therapy, Biopharmaceuticals

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $4.06M -
15 May 2018
Series A $8.00M 1
Targeted Technology
Targeted Technology
14 Apr 2015
Seed Round $2.38M -
12 Feb 2013

StemBioSys, Inc. Alternatives & Competitors

View All Alternatives
StemBioSys, Inc. vs
Aglaris Ltd Group
Aglaris Ltd Group United Kingdom

Aglaris Ltd. together with Aglaris Cell, Changing Cellular Manufacturing: More productive, more reli...

Grant
11 employees
Biotechnology, Health Care
StemBioSys, Inc. vs
China Regenerative Medicine International
China Regenerative Medicine International Hong Kong S.a.r.

Pioneering the future of regenerative medicine with advanced gene and stem cell products.

16 employees
Biotechnology, Manufacturing
StemBioSys, Inc. vs
AIVITA Biomedical, Inc.
AIVITA Biomedical, Inc. United States

"We are revolutionizing medicine using stem cells to enable drug discovery and life-changing therapi...

Venture round
17 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About StemBioSys, Inc.

Making Cell Culture Relevant
StemBioSys, Inc. was founded in 2010.
StemBioSys, Inc. is headquartered in San Antonio, United States.
StemBioSys, Inc. operates in Biotechnology and Manufacturing. Its work centres on Stem cell research, Cell culture, Regenerative medicine and Biologic matrices.
StemBioSys, Inc. has approximately 11 employees.
StemBioSys, Inc. has completed 3 funding rounds, raising a total of $14.44M. The latest funding stage is Series B.
Top alternatives and competitors to StemBioSys, Inc. include Aglaris Ltd Group, China Regenerative Medicine International, AIVITA Biomedical, Inc., RoslinCT, Cognate BioServices, a Charles River Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
StemBioSys, Inc. and Aglaris Ltd Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for StemBioSys, Inc., https://bouncewatch.com/company/stembiosys-inc-1, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout